Displaying 1 - 4 of 4
| Active Ingredient | ANTIEMETICS |
| Therapeutic Class | ANTIEMETICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIMENHYDRINATE |
| Therapeutic Class | ANTIEMETICS |
| Indications |
Prevention and treatment of nausea, vomiting and the vertigo of motion sickness. |
| Caution | Drowsiness, dry mouth. Patients should be warned against driving or performing other tasks requiring alertness. c.f. prescribing in liver and renal disease p. 13; 28. |
| Dose Range |
Adult: 50-100mg 2-3 times daily to a maximum of 300mg or 6 tabs. in 24 hours. Supp: 50-100mg 2-3 times daily . i.v: 50mg as needed. Pediatric: 2-6 years: 12.5mg;-25mg every 6-8 hours. 6- 12 y ears: 25-50mg 2-3 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DRONABINOL |
| Therapeutic Class | ANTIEMETICS |
| Indications | Synthetic form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is a More ... |
| Caution | The most frequent adverse effects of dronabinol include abdominal pain, nausea and vomiting, dizziness, euphoria, paranoid reactions, and somnolence. Seizures and seizure-like activity have been repor More ... |
| Dose Range | Nausea and vomiting associated with chemotherapy. Dose is based on body surface area and is determined by the physician. The usual initial oral dose of dronabinol is 5 mg/m2 given 1 to 3 hours before the first dose of the antineoplastic drug with subsequ |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | GRANISETRON |
| Therapeutic Class | ANTIEMETICS |
| Indications |
Management of nausea and vomiting induced by cytotoxic chemotherapy andradiotherapy, treatment of postoperative nausea and vomiting. |
| Caution | Constipation; diarrhoea; headache; insomnia. |
| Dose Range |
Adult: 1 mg, dose to be diluted to 5 mL and given over 30 seconds; maximum 3 mg p er day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |